vs
CRISPR Therapeutics AG（CRSP）与Rumble Inc.（RUM）财务数据对比。点击上方公司名可切换其他公司
CRISPR Therapeutics AG的季度营收约是Rumble Inc.的1.3倍（$35.7M vs $27.1M），CRISPR Therapeutics AG净利率更高（-104.5% vs -120.8%，领先16.2%），Rumble Inc.同比增速更快（-10.5% vs -82.3%），Rumble Inc.自由现金流更多（$-31.7M vs $-50.3M）
CRISPR Therapeutics AG是一家瑞美合资生物技术企业，总部位于瑞士楚格，在美国以CRISPR Therapeutics, Inc.名义开展业务。作为首批依托CRISPR基因编辑平台开发药物的企业之一，公司现有约500名员工，在瑞士楚格、美国波士顿、旧金山及英国伦敦设有办公点，专注于多种罕见病与常见病的治疗药物研发。
Rumble Inc.是一家加美跨国企业，主营在线视频平台、网络托管及云服务，总部位于加拿大多伦多，美国总部设在佛罗里达州朗博特基。公司由加拿大科技创业者克里斯·帕夫洛夫斯基于2013年创立，云服务板块为Truth Social提供托管支持，其视频平台在美国保守派及极右翼用户群体中广受欢迎，属于“另类科技”阵营。
CRSP vs RUM — 直观对比
营收规模更大
CRSP
是对方的1.3倍
$27.1M
营收增速更快
RUM
高出71.8%
-82.3%
净利率更高
CRSP
高出16.2%
-120.8%
自由现金流更多
RUM
多$18.6M
$-50.3M
损益表 — Q4 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $35.7M | $27.1M |
| 净利润 | $-37.3M | $-32.7M |
| 毛利率 | — | 5.5% |
| 营业利润率 | -181.0% | -131.1% |
| 净利率 | -104.5% | -120.8% |
| 营收同比 | -82.3% | -10.5% |
| 净利润同比 | -141.8% | 86.2% |
| 每股收益（稀释后） | $-0.41 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRSPRUM
| Q4 25 | — | $27.1M | ||
| Q3 25 | — | $24.8M | ||
| Q1 25 | — | $23.7M | ||
| Q4 24 | $35.7M | $30.2M | ||
| Q3 24 | — | $25.1M | ||
| Q2 24 | — | $22.5M | ||
| Q1 24 | — | $17.7M | ||
| Q4 23 | $201.2M | $20.4M |
净利润CRSPRUM
| Q4 25 | — | $-32.7M | ||
| Q3 25 | — | $-16.3M | ||
| Q1 25 | — | $-2.7M | ||
| Q4 24 | $-37.3M | $-236.8M | ||
| Q3 24 | — | $-31.5M | ||
| Q2 24 | — | $-26.8M | ||
| Q1 24 | — | $-43.3M | ||
| Q4 23 | $89.3M | $-29.3M |
毛利率CRSPRUM
| Q4 25 | — | 5.5% | ||
| Q3 25 | — | -1.8% | ||
| Q1 25 | — | -26.7% | ||
| Q4 24 | — | -14.2% | ||
| Q3 24 | — | -45.4% | ||
| Q2 24 | — | -58.8% | ||
| Q1 24 | — | -79.5% | ||
| Q4 23 | — | — |
营业利润率CRSPRUM
| Q4 25 | — | -131.1% | ||
| Q3 25 | — | -113.6% | ||
| Q1 25 | — | -153.5% | ||
| Q4 24 | -181.0% | -80.1% | ||
| Q3 24 | — | -131.0% | ||
| Q2 24 | — | -172.7% | ||
| Q1 24 | — | -197.4% | ||
| Q4 23 | 34.6% | -182.5% |
净利率CRSPRUM
| Q4 25 | — | -120.8% | ||
| Q3 25 | — | -65.7% | ||
| Q1 25 | — | -11.2% | ||
| Q4 24 | -104.5% | -783.2% | ||
| Q3 24 | — | -125.9% | ||
| Q2 24 | — | -119.2% | ||
| Q1 24 | — | -244.1% | ||
| Q4 23 | 44.4% | -143.6% |
每股收益（稀释后）CRSPRUM
| Q4 25 | — | $-0.13 | ||
| Q3 25 | — | $-0.06 | ||
| Q1 25 | — | $-0.01 | ||
| Q4 24 | $-0.41 | $-1.17 | ||
| Q3 24 | — | $-0.15 | ||
| Q2 24 | — | $-0.13 | ||
| Q1 24 | — | $-0.21 | ||
| Q4 23 | $1.12 | $-0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.9B | $237.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.9B | $274.8M |
| 总资产 | $2.2B | $336.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CRSPRUM
| Q4 25 | — | $237.9M | ||
| Q3 25 | — | $269.8M | ||
| Q1 25 | — | $301.3M | ||
| Q4 24 | $1.9B | $114.0M | ||
| Q3 24 | — | $132.0M | ||
| Q2 24 | — | $154.2M | ||
| Q1 24 | — | $183.8M | ||
| Q4 23 | $1.7B | $219.5M |
股东权益CRSPRUM
| Q4 25 | — | $274.8M | ||
| Q3 25 | — | $302.2M | ||
| Q1 25 | — | $339.6M | ||
| Q4 24 | $1.9B | $-63.1M | ||
| Q3 24 | — | $166.1M | ||
| Q2 24 | — | $192.7M | ||
| Q1 24 | — | $210.7M | ||
| Q4 23 | $1.9B | $251.6M |
总资产CRSPRUM
| Q4 25 | — | $336.8M | ||
| Q3 25 | — | $367.2M | ||
| Q1 25 | — | $391.1M | ||
| Q4 24 | $2.2B | $195.3M | ||
| Q3 24 | — | $217.2M | ||
| Q2 24 | — | $243.2M | ||
| Q1 24 | — | $263.0M | ||
| Q4 23 | $2.2B | $295.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-50.0M | $-29.4M |
| 自由现金流经营现金流 - 资本支出 | $-50.3M | $-31.7M |
| 自由现金流率自由现金流/营收 | -140.9% | -117.2% |
| 资本支出强度资本支出/营收 | 0.7% | 8.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-325.9M | $-70.8M |
8季度趋势，按日历期对齐
经营现金流CRSPRUM
| Q4 25 | — | $-29.4M | ||
| Q3 25 | — | $-10.6M | ||
| Q1 25 | — | $-14.5M | ||
| Q4 24 | $-50.0M | $-12.4M | ||
| Q3 24 | — | $-19.1M | ||
| Q2 24 | — | $-21.7M | ||
| Q1 24 | — | $-33.9M | ||
| Q4 23 | $-96.1M | $-33.1M |
自由现金流CRSPRUM
| Q4 25 | — | $-31.7M | ||
| Q3 25 | — | $-12.0M | ||
| Q1 25 | — | $-14.6M | ||
| Q4 24 | $-50.3M | $-12.4M | ||
| Q3 24 | — | $-19.9M | ||
| Q2 24 | — | $-23.1M | ||
| Q1 24 | — | $-34.3M | ||
| Q4 23 | $-96.8M | $-36.6M |
自由现金流率CRSPRUM
| Q4 25 | — | -117.2% | ||
| Q3 25 | — | -48.6% | ||
| Q1 25 | — | -61.7% | ||
| Q4 24 | -140.9% | -40.9% | ||
| Q3 24 | — | -79.5% | ||
| Q2 24 | — | -102.8% | ||
| Q1 24 | — | -193.3% | ||
| Q4 23 | -48.1% | -179.7% |
资本支出强度CRSPRUM
| Q4 25 | — | 8.5% | ||
| Q3 25 | — | 5.7% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | 0.7% | 0.1% | ||
| Q3 24 | — | 3.4% | ||
| Q2 24 | — | 6.1% | ||
| Q1 24 | — | 2.4% | ||
| Q4 23 | 0.4% | 17.5% |
现金转化率CRSPRUM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | -1.08× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRSP
| Collaboration Revenue | $35.0M | 98% |
| Grant | $2.3M | 6% |
RUM
| Audience Monetization | $23.8M | 88% |
| Other Initiatives | $3.3M | 12% |
